NEUROPROGEN
Neuroprogen GmbH is a biotechnology company that produces medicines for treatment against Parkinson's disease. The company offers in-vivo production of dopamine producing brain cells. Neuroprogen was founded in October 2001 and is based in Leipzig, Germany.
NEUROPROGEN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Leipzig, Sachsen, Germany
Country:
Germany
Website Url:
http://www.neuroprogen.de
Status:
Closed
Similar Organizations
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
AROS Applied Biotechnology
AROS Applied Biotechnology is one of the providers of genomic services for the pharma industry and universities.
Intervacc
Intervacc is a biotechnology company which develop new vaccines to meet the increasing need for effective vaccines in animal health care.
LiteVax
LiteVax is a biotechnology company that creates vaccines against infectious and non-infectious diseases.
NanoMedSyn
NanoMedSyn is a biotechnology company that provides a new generation of enzymes to treat lysosomal storage disorders.
NeuroTargets
NeuroTargets is a biotechnology company that researches and develops drugs for the treatment of neurological diseases.
TruSpine Technologies
TruSpine is a biotechnology company that develops disruptive technologies to revolutionize the spinal stabilization market.
Xeno Biosciences
Xeno Biosciences is a biotechnology company that provides novel class of treatments for metabolic diseases.
